Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308444839> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4308444839 abstract "Neutralizing monoclonal antibodies (mAbs) are highly effective in reducing hospitalization and mortality among early symptomatic COVID-19 patients in clinical trials and real-world data. While resistance to some mAbs has since emerged among new variants, characteristics associated with treatment failure of mAbs remain unknown.This multicenter, observational cohort study included patients with COVID-19 who received mAb treatment between November 20, 2020, and December 9, 2021. We utilized electronic health records from a statewide health system plus state-level vaccine and mortality data. The primary outcome was mAb treatment failure, defined as hospitalization or death within 28 days of a positive SARS-CoV-2 test.COVID-19 mAb was administered to 7406 patients. Hospitalization within 28 days of positive SARS-CoV-2 test occurred in 258 (3.5%) of all patients who received mAb treatment. Ten patients (0.1%) died within 28 days, and all but one were hospitalized prior to death. Characteristics associated with treatment failure included having two or more comorbidities excluding obesity and immunocompromised status (adjusted odds ratio [OR] 3.71, 95% confidence interval [CI] 2.52-5.56), lack of SARS-CoV-2 vaccination (OR 2.73, 95% CI 2.01-3.77), non-Hispanic black race/ethnicity (OR 2.21, 95% CI 1.20-3.82), obesity (OR 1.79, 95% CI 1.36-2.34), one comorbidity (OR 1.68, 95% CI 1.11-2.57), age ≥ 65 years (OR 1.62, 95% CI 1.13-2.35), and male sex (OR 1.56, 95% CI 1.21-2.02). Immunocompromised status (none, mild, or moderate/severe), pandemic phase, and type of mAb received were not associated with treatment failure (all p > 0.05).Comorbidities, lack of prior SARS-CoV-2 vaccination, non-Hispanic black race/ethnicity, obesity, age ≥ 65 years, and male sex are associated with treatment failure of mAbs." @default.
- W4308444839 created "2022-11-11" @default.
- W4308444839 creator A5005960274 @default.
- W4308444839 creator A5006951828 @default.
- W4308444839 creator A5015620252 @default.
- W4308444839 creator A5015816926 @default.
- W4308444839 creator A5029459847 @default.
- W4308444839 creator A5030622094 @default.
- W4308444839 creator A5040006655 @default.
- W4308444839 creator A5040402876 @default.
- W4308444839 creator A5040554237 @default.
- W4308444839 creator A5048860224 @default.
- W4308444839 creator A5069133383 @default.
- W4308444839 creator A5077236853 @default.
- W4308444839 creator A5087205547 @default.
- W4308444839 creator A5088333098 @default.
- W4308444839 date "2022-11-07" @default.
- W4308444839 modified "2023-10-07" @default.
- W4308444839 title "Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients" @default.
- W4308444839 cites W2045030413 @default.
- W4308444839 cites W2593185514 @default.
- W4308444839 cites W3081717607 @default.
- W4308444839 cites W3096658347 @default.
- W4308444839 cites W3115009914 @default.
- W4308444839 cites W3136853876 @default.
- W4308444839 cites W3157137350 @default.
- W4308444839 cites W3187850115 @default.
- W4308444839 cites W4205854655 @default.
- W4308444839 cites W4212988737 @default.
- W4308444839 cites W4224950216 @default.
- W4308444839 cites W4226004814 @default.
- W4308444839 cites W4226087845 @default.
- W4308444839 cites W4226148899 @default.
- W4308444839 cites W4280546197 @default.
- W4308444839 cites W4283074998 @default.
- W4308444839 cites W4285390939 @default.
- W4308444839 cites W4304084235 @default.
- W4308444839 cites W4307512449 @default.
- W4308444839 doi "https://doi.org/10.1186/s12879-022-07819-z" @default.
- W4308444839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36344927" @default.
- W4308444839 hasPublicationYear "2022" @default.
- W4308444839 type Work @default.
- W4308444839 citedByCount "1" @default.
- W4308444839 countsByYear W43084448392023 @default.
- W4308444839 crossrefType "journal-article" @default.
- W4308444839 hasAuthorship W4308444839A5005960274 @default.
- W4308444839 hasAuthorship W4308444839A5006951828 @default.
- W4308444839 hasAuthorship W4308444839A5015620252 @default.
- W4308444839 hasAuthorship W4308444839A5015816926 @default.
- W4308444839 hasAuthorship W4308444839A5029459847 @default.
- W4308444839 hasAuthorship W4308444839A5030622094 @default.
- W4308444839 hasAuthorship W4308444839A5040006655 @default.
- W4308444839 hasAuthorship W4308444839A5040402876 @default.
- W4308444839 hasAuthorship W4308444839A5040554237 @default.
- W4308444839 hasAuthorship W4308444839A5048860224 @default.
- W4308444839 hasAuthorship W4308444839A5069133383 @default.
- W4308444839 hasAuthorship W4308444839A5077236853 @default.
- W4308444839 hasAuthorship W4308444839A5087205547 @default.
- W4308444839 hasAuthorship W4308444839A5088333098 @default.
- W4308444839 hasBestOaLocation W43084448391 @default.
- W4308444839 hasConcept C126322002 @default.
- W4308444839 hasConcept C156957248 @default.
- W4308444839 hasConcept C203014093 @default.
- W4308444839 hasConcept C22070199 @default.
- W4308444839 hasConcept C2779159551 @default.
- W4308444839 hasConcept C44249647 @default.
- W4308444839 hasConcept C71924100 @default.
- W4308444839 hasConceptScore W4308444839C126322002 @default.
- W4308444839 hasConceptScore W4308444839C156957248 @default.
- W4308444839 hasConceptScore W4308444839C203014093 @default.
- W4308444839 hasConceptScore W4308444839C22070199 @default.
- W4308444839 hasConceptScore W4308444839C2779159551 @default.
- W4308444839 hasConceptScore W4308444839C44249647 @default.
- W4308444839 hasConceptScore W4308444839C71924100 @default.
- W4308444839 hasFunder F4320337472 @default.
- W4308444839 hasIssue "1" @default.
- W4308444839 hasLocation W43084448391 @default.
- W4308444839 hasLocation W43084448392 @default.
- W4308444839 hasLocation W43084448393 @default.
- W4308444839 hasLocation W43084448394 @default.
- W4308444839 hasOpenAccess W4308444839 @default.
- W4308444839 hasPrimaryLocation W43084448391 @default.
- W4308444839 hasRelatedWork W1967309655 @default.
- W4308444839 hasRelatedWork W2083134221 @default.
- W4308444839 hasRelatedWork W2097175706 @default.
- W4308444839 hasRelatedWork W2608661137 @default.
- W4308444839 hasRelatedWork W2781810402 @default.
- W4308444839 hasRelatedWork W2909450172 @default.
- W4308444839 hasRelatedWork W2962230309 @default.
- W4308444839 hasRelatedWork W3160138987 @default.
- W4308444839 hasRelatedWork W4205897696 @default.
- W4308444839 hasRelatedWork W4281257635 @default.
- W4308444839 hasVolume "22" @default.
- W4308444839 isParatext "false" @default.
- W4308444839 isRetracted "false" @default.
- W4308444839 workType "article" @default.